Bookmark | Print | E-Mail

Just-In-Time

Just-In-Time is one of two enrollment methods that Pharmatech Oncology utilizes to increase enrollment efficiency for clinical studies.

Just-In-Time is a patient centric approach, meaning sites look for patients prior to being opened and are only opened upon pre-identifying a patient. Once a patient has been pre-identified using standard of care, the sites are open in an expedited manner. This means that Pharmatech Oncology's entire network of 1,200 investigators can be looking for patients without being opened and incurring the cost. Ultimately, one of the best ways to guaranty that studies meet enrollment objectives would be to have every single oncologist in the US looking for patients that qualify for your study, however, cost and logistical considerations considerably limit the activities to a small number of sites. Just-In-Time is the next best thing, whereas 1,200 oncologists look for patients without cost to sponsors and are only opened when the first patient is pre-identified.

The Benefits of Just-In-Time include:

• Increased Patient Accrual Rates
• Search Much Larger Pool Of Patients, Without Additional Costs
• Eliminate Non-Accruing Sites
• Reduce Study Costs
• Improved Sites Study Awareness
• Most Efficient Enrollment Logistics In the Industry

Pharmatech Oncology also provides the traditional approach for enrollment of opening a fixed number of sites to accrue patients, since certain cancer indications requires this approach. Contact us to discuss the details the Just-In-Time and how it can benefit your oncology program.